Specific Tear IgE in Patients with Moderate-to-Severe Autumnal Allergic Conjunctivitis

被引:12
|
作者
Mimura, Tatsuya [1 ,2 ,3 ]
Usui, Tomohiko [2 ]
Mori, Mikiro [3 ]
Funatsu, Hideharu [4 ]
Noma, Hidetaka [4 ]
Amano, Shiro [2 ]
机构
[1] Toranomon Gen Hosp, Dept Ophthalmol, Minato Ku, Tokyo 1058470, Japan
[2] Univ Tokyo, Dept Ophthalmol, Grad Sch Med, Tokyo 113, Japan
[3] Okinaka Mem Inst Med Res, Dept Ophthalmol, Tokyo, Japan
[4] Tokyo Womens Med Univ, Dept Ophthalmol, Yachiyo Med Ctr, Chiba, Japan
关键词
Allergic conjunctivitis; Immfast Check J1 (R); Immunochromatography; Tear; Specific IgE; IMMUNOGLOBULIN-E; MOLECULES;
D O I
10.1159/000323908
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Recently, a new commercial test for specific IgE based on immunochromatography (Immfast Check J1 (R)) has been developed. We previously reported on the use of this kit for tear fluid samples during spring. In this study, we compared the level of specific IgE in tear fluid among patients with seasonal allergic conjunctivitis during spring or autumn and control subjects. Methods: A nonrandomized, cross-sectional study was conducted in patients with moderate-to-severe allergic conjunctivitis occurring in spring (n = 56, spring group) or autumn (n = 52, autumn group), as well as in age- and sex-matched healthy control subjects (n = 50, control group). Levels of specific IgE for cedar pollen, cat epithelium and Dermatophogoides pteronyssinus were measured in tear fluid with the Immfast Check J1. Results: Specific IgE scores for cedar pollen and D. pteronyssinus were significantly higher in the spring and autumn groups than in the control group (p < 0.0001). In the autumn group, the highest detection rate for a specific allergen was 96.2% for D. pteronyssinus, followed by cedar pollen (86.5%) and cat epithelium (25.5%). In the spring group, the highest detection rate was 98.3% for cedar pollen, followed by D. pteronyssinus (51.7%) and cat epithelium (19.0%). Conclusions:These results suggest that both house dust mite allergen and outdoor allergens such as cedar pollen can be causes of allergic conjunctivitis during both spring and autumn in Japan. The Immfast Check J1 provides rapid measurement of specific IgE in tear fluid, which allows easy diagnosis of allergic conjunctivitis in an outpatient setting. Copyright (C) 2011 S. Karger AG, Basel
引用
收藏
页码:381 / 386
页数:6
相关论文
共 50 条
  • [41] Dupilumab Effect on Lung Function in Patients with Uncontrolled, Moderate-to-Severe Asthma with an Allergic Phenotype
    Castro, M.
    Corren, J.
    Casale, T. B.
    Quirce, S.
    Rice, M. S.
    Deniz, Y.
    Rowe, P.
    Amin, N.
    Teper, A.
    PNEUMOLOGIE, 2020, 74 : S89 - S89
  • [42] Effectiveness of omalizumab across different dosing regimens in patients with moderate-to-severe allergic asthma
    Chase, Nicole M.
    Littlejohn, Monica
    Holweg, Cecile T. J.
    Millette, Lauren A.
    Seetasith, Arpamas
    Steinke, John W.
    Trzaskoma, Benjamin L.
    Hanania, Nicola A.
    Casale, Thomas B.
    RESPIRATORY MEDICINE, 2024, 223
  • [43] Dupilumab Effect on Lung Function in Patients With Uncontrolled, Moderate-to-Severe Asthma With an Allergic Phenotype
    Castro, Mario
    Corren, Jonathan
    Casale, Thomas B.
    Quirce, Santiago
    Rice, Megan S.
    Deniz, Yamo
    Rowe, Paul
    Amin, Nikhil
    Teper, Ariel
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [44] Impact of omalizumab on quality-of-life outcomes in patients with moderate-to-severe allergic asthma
    Niebauer, K
    Dewilde, S
    Fox-Rushby, J
    Revicki, DA
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2006, 96 (02) : 316 - 326
  • [45] QUANTIFYING THE DEGREE OF OVERLAP BETWEEN ALLERGIC AND EOSINOPHILIC SUBTYPES IN PATIENTS WITH MODERATE-TO-SEVERE ASTHMA
    Chen, M.
    Shepard, K., II
    Holweg, C.
    Rajput, Y.
    Ahmed, A.
    Yang, M.
    Raut, P.
    Pazwash, H.
    Choo, E.
    VALUE IN HEALTH, 2019, 22 : S350 - S350
  • [46] DUPILUMAB DECREASES TOTAL AND ALLERGEN-SPECIFIC IGE IN ADOLESCENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS (AD)
    Simpson, E.
    Cork, M.
    Arkwright, P.
    Deleuran, M.
    Chen, Z.
    Rodriguez Marco, A.
    Cyr, S.
    Harel, S.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (05) : S54 - S55
  • [47] Conjunctivitis in adult patients with moderate-to-severe atopic dermatitis: results from five tralokinumab clinical trials
    Wollenberg, A.
    Beck, L. A.
    Weller, M. Bruin
    Simpson, E. L.
    Imafuku, S.
    Boguniewicz, M.
    Zachariae, R.
    Olsen, C. K.
    Thyssen, J. P.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (03) : 453 - 465
  • [48] Olfactory dysfunction in Japanese children with moderate-to-severe allergic rhinitis
    Suzuki, Ryohei
    Mori, Eri
    Iwasaki, Hijiriko
    Shimamura, Yosuke
    Shigeta, Yasushi
    Sagara, Nagatoshi
    Aota, Akiko
    Akashi, Kenichi
    Toyoda, Keiko
    Katsunuma, Toshio
    AURIS NASUS LARYNX, 2023, 50 (06) : 904 - 910
  • [49] Omalizumab: An update on efficacy and safety in moderate-to-severe allergic asthma
    Chipps, Bradley E.
    Figliomeni, Maria
    Spector, Sheldon
    ALLERGY AND ASTHMA PROCEEDINGS, 2012, 33 (05) : 377 - 385
  • [50] Tear levels of neuropeptides increase after specific allergen challenge in allergic conjunctivitis
    Sacchetti, Marta
    Micera, Alessandra
    Lambiase, Alessandro
    Speranza, Stefania
    Mantelli, Flavio
    Petrachi, Girolamo
    Bonini, Sergio
    Bonini, Stefano
    MOLECULAR VISION, 2011, 17 (6-7): : 47 - 51